维普中文期刊产品整合服务
87篇 您的检索式:作者名="RINI S"
    题名 作者 年代 出处 被引量
1Kinetic aspects of the glass transition behavior of maltose-water mixtures显示文摘Noel T R Riny S G Whittam M A 1991Carbohydrates Research1991,,212:1
2Sunitinib mediates reversal of myeloid-derived suppressor cell accumulation in renal cell carcinoma patients显示文摘Ko J S Zea A H Rini B I 2009Clin Cancer Res2009,15,6:1
3Local interleukin-10 production during respiratory syncytial virus bronchiolitis is associatedwith post-bronchiolitis wheeze显示文摘Annemieke S Riny J Haunekede G 2011Respir Res2011,12,1:1
4CCR7-mediated physiological lymphocyte homing involves activation of a tyrosine kinase pathway显示文摘Stein J V Soriano S F M'rini C 2003Blood2003,101,1:1
5Phase ffl trial of bevaci-zumab plus interferon alfa versus interferon alfa monotherapy in pa-tients with metastatic renal cell carcinoma : Final results of CALGB90206 显示文摘Rini BI Halabi S’ Rosenberg JE 2010J Clin Oncol2010,28,13:1
6Cancer and Leukemia Group B 90206:a randomized phase Ⅲ trial of interferon-alpha or interferon alpha plus anti-vascular endothelial growth factor antibody(bevacizumab) in metastatic renal cell carcinoma显示文摘 Halabi S Taylor J 2004Clin Cancer Res2004,10,8:1
7Sunitinib mediates reversal of myeioid-derived suppressor cell accumulation in renal cell carcinoma patients显示文摘KO J S ZEA A H RINI B I 2009Clin Cancer Res2009,15,6:1
8Bevacizumab plus interferon alfa compared with interferon alfa monotherapy in patients with metastatic renal cell carcinoma: CALGB 90206 显示文摘Rini BI Halabi S Rosenberg JE 2008J Clin Oneol2008,26,33:1
9A phase II study of gemcitabine and capecitabine in metastatic renal cancer: a report of Cancer and Leukemia Group B pro- tocolg0008显示文摘Stadler W M Halabi S Rini B 2006Cancer2006,107,6:1
10On the Capacity of the multian-tenna Gaussian cognitive interference channel显示文摘RINI S GOLDSMITH A 2014IEEEJournal on Selected Areas in Communications2014,32,11:1
11Effect of different disinfection protocols on microbial and biofilm contamination of dental unit waterlines in community dental pratices显示文摘Dallolio L Scuderi A Rini M S 2014Int J Environ Res Public Health2014,11,2:1
12Posterior capsule opacification: experimental analyses 显示文摘ODRICH MG HALL S J WORGUL BV TROKEL SL RINI FJ 1985Ophthalmic Res1985,17,2:1
13Phase III tri- al of bevacizumab plus interferon alfa versus interferon alfa monotherapy in patients with metastatic renal cell carcinoma: final results of CALGB 90206 显示文摘Rini BI Halabi S Rosenberg JE 2010J Clin Oncol2010,28,13:1
14Phase III trial of bevaei- zumab plus interferon alfa versus interferon alfa monotherapy in patients with metastatic renal cell careinoma:final results of CAL- GB 90206 显示文摘Rini B1 Halabi S Rosenberg JE 2010J Clin Onco12010,28,13:1
15Bevacizumab plus interferon alfa compared with interferon alfa monotherapy in patients with metastatic renal cell carcinoma:CALGB 90206 显示文摘Rini BI Halabi S Rosenberg JE 2008J Clin Oncol2008,26,33:1
16PhaseⅢtrial of bevacizumab plus interferon alpha versus interferon alpha immunotherapy in patients with metastatic renal cell carcinoma:final results of CALGB 90206显示文摘Rini BI Halabi S Rosenberg JE 2010J Clin Oncol2010,28,13:1
17Bevaeizumab plus in- terferon alfa compared with interferon alfa monotherapy in patients with metastatic renal cell carcinoma: CALGB 90206 显示文摘Rini BI Halahi S Rosenberg JE 2008J Clin Oncoi2008,26,33:1
18Renal cell carcinoma显示文摘Rini B I Campbell S C Escudier B 2009The Lancet2009,373,9669:1
19The use of bevacizumab with docetaxel and estramustine in hormone refractory prostate cancer:initial results of CALGB 90006显示文摘PICUS J HALABI S RINI B 2003J Clin Oncol2003,,:1
20Phase III trial of bevaci-zumab plus interferon alfa versus interferon alfa monotherapy inpatients with metastatic renal cell carcinoma : final results of CAL-GB 90206 显示文摘Rini BI Halabi S Rosenberg JE 2010J Clin Oncol2010,28,13:1
返回顶部 每页显示:
共5页 首页 上一页 第1页 下一页 末页 /5 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费